Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Legislators And Bond Holders Knocking At Valeant’s Door

This article was originally published in The Pink Sheet Daily

Executive Summary

The troubled drug maker received a notice of default from bondholders, while CEO Michael Pearson agreed to be deposed by the Senate’s Special Committee on Aging April 18.


Related Content

Valeant’s Pearson Is Out, As Hunt Begins For A CEO To Right The Wrongs
At Drug Pricing Hearing, Innovator Companies Mainly Escape Congressional Wrath


Related Companies